Tag: chief executive officer
India’s first focused health AI Conclave unites doctors and AI experts
The inaugural edition of the HAI Conclave 2026, a national platform dedicated exclusively to Healthcare and Artificial Intelligence (AI), brought together clinicians, AI scientists,...
Call for sustainable transformation and AI value creation healthcare
As healthcare systems across Asia accelerate investments in artificial intelligence (AI), digital platforms, and data-driven care, increasing attention is being placed on the leadership...
Pierre Fabre receives EC nod for colorectal cancer drug
Laboratoires Pierre Fabre has announced that the European Commission (EC) has approved Braftovi (encorafenib) in combination with cetuximab and FOLFOX for the first-line treatment...
Verista announces appointment of Michael Laferrera as chief executive officer
Verista, a leading provider of automation, compliance, and quality solutions for the life sciences industry, announces the appointment of Michael J. Laferrera as chief...
Gilead Sciences acquires Ouro Medicines for over US$2 billion
Gilead Sciences, Inc. announced it has entered into a definitive agreement to acquire Ouro Medicines, a privately held biotechnology company focused on developing T...
Philips proposes new appointment and re-appointments to its supervisory board and...
Royal Philips, a global leader in health technology, has announced a proposed Supervisory Board appointment and re-appointments, in addition to the previously announced proposal...
Lynk Pharma’s positive results in dermatitis treatment
Lynk Pharmaceuticals, a clinical-stage innovative drug development company focused on therapies for immune and inflammatory diseases, has announced positive topline results from its Phase...
2026 edition of Gustave Roussy Prize awarded to Luis Diaz
An international leader in colorectal cancers, immunotherapy, and liquid biopsy, Prof. Luis Diaz Jr. has been awarded the Gustave Roussy Award for his work...
Clover initiates phase 2 clinical trial for RSV + hMPV ±...
Clover Biopharmaceuticals, a global commercial-stage biotechnology company committed to unleashing the power of innovative vaccines to save lives and improve health around the world,...
Phase 2 trial of AP31969 in patients with atrial fibrillation
Acesion Pharma, a biotech company pioneering treatments for atrial fibrillation, the most common cardiac arrhythmia, has announced enrolment of the first patients in its...